BACKGROUND Malignant pleural effusions are a common cause of morbidity in patients with advanced cancers. Common malignancies associated with malignant pleural effusion include lung, breast and lymphomas. Diagnostic…
BACKGROUND Malignant pleural effusions are a common cause of morbidity in patients with advanced cancer. Cancer of the lung breast and lymphomas account for approximately 75 % of malignant pleural effusions ... Sarcomas…
INTRODUCTION Malignant pleural effusion (MPE) is one of the commonest causes of pleural effusion in Myanmar. The diagnosis of MPE can be sometimes difficult to make because of the inconclusive ... study are to review…
Background: Malignant Pleural Effusion (MPE) is a complication of advanced malignancy occurring commonly in patients with lung cancer, lymphoma and breast cancer. Pleurodesis is often used to prevent re-accumulation…
Malignant Pleural Effusion (MPE) is occurred in about 15% of all patients with cancer especially in lung cancer. Pleurodesis using Bleomycin and povidoneiodine to palliate symptoms of MPE. This study ... retrospective…
disease, known as Malignant Pleural Effusion (MPE), is present in 15% of cancer patients. Finding the right treatment is crucial given the short overall survival rate. It should be determined
CYFRA 21-1 in pleural effusions may help establish the diagnosis of Malignant Pleural Effusion (MPE). However, given the relatively low sensitivity, it is often used in combination with other
From December 2004 to December 2014, a total of 79 patients with Malignant Pleural Effusion (MPE) were randomly divided into the control group (C, n=37) and the treatment group
through pleural catheterization using talc slurry, bleomycin, and tetracycline in patients with symptomatic malignant pleural effusion (MPE) and to compare the efficacy, reliability and outcomes of these agents…
intrapleural perfusion with pemetrexed disodium in the treatment of lung adenocarcinoma complicated with malignant pleural effusion and its influence on carcinoembryonic antigen levels in pleural effusion. 105 patients…
Objective: To determine the efficacy of doxycycline as pleuridising agent in cases of malignant pleural effusions (MPE). Subject and methods: This was a descriptive case series that was conducted ... Lahore from January…
will extend the use of clinical metabonomics to develop new screening test for malignant pleural effusions (MPE). Methods: 32 malignant and 18 non-malignant PE samples will be analyzed using ... with sensitivity of 84%…
Malignant pleural effusion (MPE) is a frequent complication in patients who have a broad range of advanced cancers, including lymphomas and carcinomas of the lung, breast, gastrointestinal tract, and ovaries…
each year. This is a Prospective and Observational Study. All patients diagnosed to have pleural effusion by xray, clinical examination and ultrasound examination of pleura if needed will undergo informed ... patients…
pleural fluid wecan use of tumor markers and other biomarkers to better diagnose malignant pleural effusion. Inthe previous studies by using immunochemical approach, interleukin-17 and also CEA expressin more…
with exudative pleural effusion and compared among two groups including 34 patients with malignant pleural effusion (MPE) and 56 patients with benign pleural effusion (BPE) in Sayyad Shirazi Hospital ... higher levels…
histopathologically-proven carcinoma oesophagus who had thoracic complications in addition to features of malignancy and metastases were retrospectively analysed. The various pulmonary and thoracic complications in…
Introduction: While the malignant cells in the fluid are available in malignant pleural effusions (MPE), in paramalignant pleural effusions (PMPE), the malignant cells do not exist. We aimed to compare ... feature were…
false negative cytological analysis. Thoracoscopy remains the gold standard to distinguish benign from malignant pleural effusion, but it is invasive and not suitable for all patients. Microparticles (MPs) are promising…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.